Company Filing History:
Years Active: 2010-2014
Title: The Innovative Contributions of Petr Hruby in Pharmaceutical Patents
Introduction: Petr Hruby, an accomplished inventor based in Prague, CZ, has made significant strides in the field of pharmaceuticals. With two impactful patents to his name, he has contributed to the advancement of medication formulations, showcasing his dedication to innovation and the development of effective pharmaceutical compounds.
Latest Patents: Hruby's latest patents focus on novel salts of desvenlafaxine and methods of their preparation. One patent details new salts of desvenlafaxine combined with oxalic acid, specifically the hydrogen oxalate and hemioxalate forms. These salts exhibit unique properties due to their specific proportions of desvenlafaxine to oxalic acid. Additionally, he has developed a method for preparing (S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine, involving the reaction of a precursor compound with an optically active acid, leading to a potentially valuable pharmaceutical product.
Career Highlights: Throughout his career, Petr Hruby has been employed by Zentiva, an established pharmaceutical company that specializes in the development and production of generic and proprietary medicines. His work with Zentiva has allowed him to focus on innovation in drug formulation, making him a recognized figure in the field.
Collaborations: Hruby has collaborated with notable coworkers, including Ludek Ridvan and Stanislav Radl. Together, they have combined their expertise to drive forward the research and development of innovative pharmaceutical solutions.
Conclusion: Petr Hruby’s contributions to the field of pharmaceuticals exemplify the impact of dedicated inventors in advancing medical treatments. His innovative work on desvenlafaxine salts and other compounds illustrates the importance of ongoing research and collaboration in creating effective medical solutions.